Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Harvard Business School
Fuji
Merck
McKesson
McKinsey
Express Scripts
US Army
Covington

Generated: January 18, 2018

DrugPatentWatch Database Preview

Actavis Mid Atlantic Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-nine approved drugs.



Summary for Actavis Mid Atlantic
US Patents:0
Tradenames:57
Ingredients:47
NDAs:69

Drugs and US Patents for Actavis Mid Atlantic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic ACETASOL HC acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 087143-001 Jan 13, 1982 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 204965-001 Nov 7, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic LEVETIRACETAM levetiracetam SOLUTION;ORAL 078976-001 Jan 15, 2009 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 086578-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic ACYCLOVIR acyclovir SUSPENSION;ORAL 074738-001 Apr 28, 1997 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic ENULOSE lactulose SOLUTION;ORAL, RECTAL 071548-001 Aug 15, 1988 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic IBUPROFEN ibuprofen SUSPENSION;ORAL 074978-001 Mar 25, 1998 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090378-001 May 9, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 071012-001 Feb 3, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070051-001 Oct 10, 1984 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
Chubb
Merck
Cantor Fitzgerald
Johnson and Johnson
Cerilliant
Deloitte
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot